About
Christopher J. DelOrefice was appointed Chief Financial Officer of Ulta Beauty effective December 5, 2025, overseeing the company's accounting, finance, tax, treasury, procurement, and investor relations functions. He joined Ulta Beauty from Becton Dickinson & Company, where he had served as Executive Vice President and Chief Financial Officer since September 2021, and earlier spent more than 20 years at Johnson & Johnson in senior finance roles including Vice President of Investor Relations. He holds B.S. and M.B.A. degrees from Villanova University, is a (inactive) CPA, and serves as a director and audit committee chair of ResMed.
Roles
Ulta Beauty, Inc.
Chief Financial Officer · Current role
2025–present
Becton Dickinson & Company
Executive Vice President & Chief Financial Officer
—
Johnson & Johnson
Vice President, Investor Relations
—
AstraZeneca Pharmaceuticals
Finance leadership roles
—
Ametek, Inc.
Finance leadership roles
—
External Roles
ResMed Inc.
Director and Audit Committee Chair
—
Fixed Compensation
FY 2025Salary
$154,540
ComponentProrated base salary from December 5, 2025 start; annual rate $980,000
Bonus
$1,000,000
FormSign-on / make-whole cash bonus
All other compensation
$13,900
Includes401(k) match $13,800 and other perquisites $100
Total compensation
$4,469,098
Performance Compensation
Data from FY 2025Cash incentive
Non-equity incentive plan compensation
$0
Target Opportunity
—
NoteNot eligible for a fiscal 2025 annual incentive given his December 2025 appointment
Stock awards
Stock awards
$3,300,658
FormRestricted stock units, including make-whole equity
Also at Ulta Beauty, Inc.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.